KalVista Pharmaceuticals (KALV) CMO Sells $71,916 in Company Stock

KalVista Pharmaceuticals (KALV) announced that its Chief Medical Officer, Audhya, sold $71,916 worth of company stock. This transaction indicates active management participation in the market and may impact investor perceptions. The sale's timing and amount could reflect the company's current performance or future outlook. Monitoring insider transactions like this is essential for investors to assess potential market reactions and to understand insider confidence in the company's direction.